154 related articles for article (PubMed ID: 29080392)
1. Plumbagin-mediating GLUT1 suppresses the growth of human tongue squamous cell carcinoma.
Na S; Zhang J; Zhou X; Tang A; Huang D; Xu Q; Xue D; Qiu J
Oral Dis; 2018 Sep; 24(6):920-929. PubMed ID: 29080392
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity mechanisms of plumbagin in drug-resistant tongue squamous cell carcinoma.
Xue D; Zhou X; Qiu J
J Pharm Pharmacol; 2021 Mar; 73(1):98-109. PubMed ID: 33791802
[TBL] [Abstract][Full Text] [Related]
3. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells.
Pan ST; Qin Y; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1601-26. PubMed ID: 25834400
[TBL] [Abstract][Full Text] [Related]
4. Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-mediated signaling pathway in human tongue squamous cell carcinoma cells.
Pan ST; Qin Y; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Zhou SF; Qiu JX
Drug Des Devel Ther; 2015; 9():5511-51. PubMed ID: 26491260
[TBL] [Abstract][Full Text] [Related]
5. [Effect of plumbagin on epithelial-mesenchymal transition and underlying mechanisms in human tongue squamous cell carcinoma cells].
Li B; Pan ST; Qiu JX
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Jul; 52(7):421-426. PubMed ID: 29972906
[No Abstract] [Full Text] [Related]
6. Plumbagin Enhances the Anticancer Efficacy of Cisplatin by Increasing Intracellular ROS in Human Tongue Squamous Cell Carcinoma.
Xue D; Pan ST; Zhou X; Ye F; Zhou Q; Shi F; He F; Yu H; Qiu J
Oxid Med Cell Longev; 2020; 2020():5649174. PubMed ID: 32308804
[TBL] [Abstract][Full Text] [Related]
7. Obovatol inhibits the growth and aggressiveness of tongue squamous cell carcinoma through regulation of the EGF‑mediated JAK‑STAT signaling pathway.
Duan M; Du X; Ren G; Zhang Y; Zheng Y; Sun S; Zhang J
Mol Med Rep; 2018 Aug; 18(2):1651-1659. PubMed ID: 29845251
[TBL] [Abstract][Full Text] [Related]
8. The growth inhibitory effect of human gingiva-derived mesenchymal stromal cells expressing interferon-β on tongue squamous cell carcinoma cells and xenograft model.
Du L; Liang Q; Ge S; Yang C; Yang P
Stem Cell Res Ther; 2019 Jul; 10(1):224. PubMed ID: 31358054
[TBL] [Abstract][Full Text] [Related]
9. Integrin α7 correlates with worse clinical features and prognosis, and its knockdown inhibits cell proliferation and stemness in tongue squamous cell carcinoma.
Lv Z; Yang Y; Yang C
Int J Oncol; 2020 Jan; 56(1):69-84. PubMed ID: 31789398
[TBL] [Abstract][Full Text] [Related]
10. Mena as a key enhancer factor of EMT to promote metastasis of human tongue squamous cell carcinoma.
Cui H; Liang X; Zhu Y; Elayah SA; Qi H; Xie L; Guo Z; Siya F; Ming Y; Yuxin G; Tu J; Na S
Oral Dis; 2024 May; 30(4):2084-2096. PubMed ID: 37203597
[TBL] [Abstract][Full Text] [Related]
11. High expression of TMEM40 contributes to progressive features of tongue squamous cell carcinoma.
Zhang Q; Huang D; Zhang Z; Feng Y; Fu M; Wei M; Zhou J; Huang Y; Liu S; Shi R
Oncol Rep; 2019 Jan; 41(1):154-164. PubMed ID: 30320346
[TBL] [Abstract][Full Text] [Related]
12. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor.
Li J; Huang H; Sun L; Yang M; Pan C; Chen W; Wu D; Lin Z; Zeng C; Yao Y; Zhang P; Song E
Clin Cancer Res; 2009 Jun; 15(12):3998-4008. PubMed ID: 19509158
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of the plant extract morin in tongue squamous cell carcinoma cells.
Ji Y; Jia L; Zhang Y; Xing Y; Wu X; Zhao B; Zhang D; Xu X; Qiao X
Oncol Rep; 2018 Nov; 40(5):3024-3032. PubMed ID: 30132559
[TBL] [Abstract][Full Text] [Related]
14. Glaucocalyxin A induces apoptosis and autophagy in tongue squamous cell carcinoma cells by regulating ROS.
Shi F; Xue D; Jiang Q; Qiu J
Cancer Chemother Pharmacol; 2021 Aug; 88(2):235-246. PubMed ID: 33904969
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein is associated with the development of tongue squamous cell carcinoma.
Du J; Hu W; Yang C; Wang Y; Wang X; Yang P
Acta Biochim Biophys Sin (Shanghai); 2018 Mar; 50(3):238-245. PubMed ID: 29385406
[TBL] [Abstract][Full Text] [Related]
16. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
Zhang H; Sun JD; Yan LJ; Zhao XP
Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215
[TBL] [Abstract][Full Text] [Related]
17. Silencing RhoA inhibits migration and invasion through Wnt/β-catenin pathway and growth through cell cycle regulation in human tongue cancer.
Yan G; Zou R; Chen Z; Fan B; Wang Z; Wang Y; Yin X; Zhang D; Tong L; Yang F; Jiang W; Fu W; Zheng J; Bergo MO; Dalin M; Zheng J; Chen S; Zhou J
Acta Biochim Biophys Sin (Shanghai); 2014 Aug; 46(8):682-90. PubMed ID: 25001480
[TBL] [Abstract][Full Text] [Related]
18. Beclin1 inhibits proliferation, migration and invasion in tongue squamous cell carcinoma cell lines.
Weng J; Wang C; Wang Y; Tang H; Liang J; Liu X; Huang H; Hou J
Oral Oncol; 2014 Oct; 50(10):983-90. PubMed ID: 25096824
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen cell adhesion molecule 1 inhibits the antitumor effect of neutrophils in tongue squamous cell carcinoma.
Wang N; Wang Q; Chi J; Xiang F; Lin M; Wang W; Wei F; Feng Y
Cancer Sci; 2019 Feb; 110(2):519-529. PubMed ID: 30565803
[TBL] [Abstract][Full Text] [Related]
20. Distribution of Hypoxia-Inducible Factor-1α and Glucose Transporter-1 in Human Tongue Cancers.
Vasconcelos MG; Vasconcelos RG; Pereira de Oliveira DH; de Moura Santos E; Pinto LP; da Silveira ÉJ; Queiroz LM
J Oral Maxillofac Surg; 2015 Sep; 73(9):1753-60. PubMed ID: 25863229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
